DCLK1诱导了一种亲瘤原型的表型,以驱动胃癌的进展
Shoukat Afshar-Sterle1,2, Annalisa L E Carli1,2, Ryan O'Keefe1,2
1Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.
Science signaling
|September 17, 2024
概括
双丁类激酶1 (DCLK1) 驱动胃癌的侵袭和转移. 抑制DCLK1激酶活性抑制了瘤的生长和扩散,将其确定为潜在的治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 双丁类激酶1 (DCLK1) 被认为是胃癌 (GC) 的驱动因素.
- DCLK1具有激酶活性,酸化氨酸和氨酸残留物,这表明它在细胞过程中发挥了作用.
研究的目的:
- 调查DCLK1激酶活性在胃癌细胞入侵和转移中的作用.
- 确定DCLK1激酶活性是否是胃癌的可行的治疗标.
主要方法:
- 使用了MKN1人类胃癌细胞,包括那些具有野生型DCLK1,激酶不活性DCLK1突变 (MKN1D511N) 和DCLK1过度表达 (MKN1DCLK1) 的细胞.
- 在皮下异种移植模型中评估瘤生长,在小鼠的 ортотоп移植模型中评估侵袭性/转移性.
- 分析了体标志物 (α-Sma,维丁,原) 和化学因CXCL12表达.
主要成果:
- 抑制DCLK1激酶活性降低了瘤生长, stromal标记物丰富性和体外迁移潜力.
- 过度表达DCLK1增加了侵入性和肺转移发病率.
- 鉴定出CXCL12是DCLK1在胃癌进展中的下游效应因子.
结论:
- DCLK1激酶活性对于编排胃癌细胞的亲侵入性和亲转移性重编程至关重要.
- 向DCLK1激酶活性有效地逆转了前瘤和前转移的表型.
- DCLK1代表了胃癌的广泛作用和潜在的向性促进体.
相关概念视频
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


